Mostrar registro simples

dc.date.accessioned2015-08-25T14:54:25Z
dc.date.available2015-08-25T14:54:25Z
dc.date.issued1999es_ES
dc.identifier.citation(1999) Programa de detección de fallas de calidad en los medicamentos comercializados. Rev Panam Salud Publica;6(3) -,sept. 1999. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000800014&lng=pt&nrm=isoes_ES
dc.identifier.urihttp://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891999000800014&lng=pt&nrm=isoes_ES
dc.identifier.urihttps://iris.paho.org/handle/10665.2/8897
dc.format.extentiluses_ES
dc.format.extenttabes_ES
dc.relation.ispartofseriesRev Panam Salud Publica;6(3),sept. 1999es_ES
dc.subjectQualidade dos Medicamentos Homeopáticospt_BR
dc.subjectDeterminaçãopt_BR
dc.subjectVigilância de Produtos Comercializadoses_ES
dc.titlePrograma de detección de fallas de calidad en los medicamentos comercializadoses_ES
dc.title.alternativeA program to detect defective drugs in the postmarketing perioden_US
dc.typeJournal articlesen_US
dc.rights.holderPan American Health Organizationen_US
dc.description.notesDefective drugs have been found during the postmarketing phase in various countries, regardless of those nations' level of economic development. This paper proposes guidelines for a program to uncover drug defects in the postmarketing surveillance period. Such a program should be run by a center or service organized for that purpose within the framework of a national drug surveillance systemen_US


Arquivos deste item

Thumbnail

Este item aparece na(s) seguinte(s) coleção(s)

Mostrar registro simples